It was objectionable not rejected claim 41 and basically means nothing which is what the examiners says. It is what Zec does not post up that people should go and read for themselves.
- Forums
- ASX - By Stock
- NOX
- Ann: Noxopharm Secures Key European Patent Allowance for Veyonda
Ann: Noxopharm Secures Key European Patent Allowance for Veyonda, page-38
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
7.2¢ |
Change
-0.003(4.00%) |
Mkt cap ! $21.04M |
Open | High | Low | Value | Volume |
7.2¢ | 7.2¢ | 7.2¢ | $934 | 12.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 37034 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.8¢ | 109003 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 37034 | 0.072 |
2 | 20587 | 0.068 |
1 | 100000 | 0.067 |
2 | 76672 | 0.066 |
1 | 15000 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.078 | 109003 | 1 |
0.079 | 21113 | 2 |
0.080 | 112099 | 3 |
0.081 | 22345 | 2 |
0.086 | 100000 | 1 |
Last trade - 11.41am 18/07/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |